Janus Henderson Group PLC Sells 146,139 Shares of Progyny, Inc. (NASDAQ:PGNY)

Janus Henderson Group PLC cut its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 29.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 343,238 shares of the company's stock after selling 146,139 shares during the quarter. Janus Henderson Group PLC owned about 0.40% of Progyny worth $5,922,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Voya Investment Management LLC grew its position in Progyny by 1.4% in the 4th quarter. Voya Investment Management LLC now owns 51,792 shares of the company's stock valued at $893,000 after buying an additional 701 shares in the last quarter. Signaturefd LLC grew its position in Progyny by 1,355.0% in the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company's stock valued at $25,000 after buying an additional 1,355 shares in the last quarter. Nisa Investment Advisors LLC grew its position in Progyny by 108.4% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock valued at $51,000 after buying an additional 1,526 shares in the last quarter. KBC Group NV grew its position in Progyny by 84.6% in the 4th quarter. KBC Group NV now owns 4,669 shares of the company's stock valued at $81,000 after buying an additional 2,140 shares in the last quarter. Finally, F M Investments LLC grew its position in Progyny by 13.0% in the 4th quarter. F M Investments LLC now owns 20,420 shares of the company's stock valued at $352,000 after buying an additional 2,342 shares in the last quarter. Institutional investors own 94.93% of the company's stock.

Progyny Stock Performance

Shares of NASDAQ PGNY traded down $0.37 during mid-day trading on Friday, reaching $20.52. The company had a trading volume of 822,500 shares, compared to its average volume of 1,712,711. The stock has a fifty day moving average of $22.15 and a two-hundred day moving average of $19.96. The company has a market capitalization of $1.76 billion, a price-to-earnings ratio of 35.38, a PEG ratio of 2.39 and a beta of 1.37. Progyny, Inc. has a 12-month low of $13.39 and a 12-month high of $30.42.

Progyny (NASDAQ:PGNY - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.28). The company had revenue of $324.04 million during the quarter, compared to analysts' expectations of $307.86 million. Progyny had a return on equity of 11.36% and a net margin of 5.03%. Progyny's revenue for the quarter was up 16.5% compared to the same quarter last year. During the same period last year, the company earned $0.17 earnings per share. Sell-side analysts forecast that Progyny, Inc. will post 0.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PGNY has been the subject of several research reports. JPMorgan Chase & Co. raised their price objective on shares of Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research report on Tuesday, January 28th. Canaccord Genuity Group reduced their price objective on shares of Progyny from $23.00 to $21.00 and set a "hold" rating for the company in a research report on Monday, May 12th. Bank of America raised their price objective on shares of Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. Finally, BTIG Research upgraded shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a research report on Monday, March 31st. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $23.45.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.